1. Home
  2. PRE vs IGA Comparison

PRE vs IGA Comparison

Compare PRE & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRE
  • IGA
  • Stock Information
  • Founded
  • PRE 2014
  • IGA 2005
  • Country
  • PRE Hong Kong
  • IGA United States
  • Employees
  • PRE N/A
  • IGA N/A
  • Industry
  • PRE Biotechnology: Laboratory Analytical Instruments
  • IGA Investment Managers
  • Sector
  • PRE Industrials
  • IGA Finance
  • Exchange
  • PRE Nasdaq
  • IGA Nasdaq
  • Market Cap
  • PRE 131.3M
  • IGA 151.6M
  • IPO Year
  • PRE N/A
  • IGA N/A
  • Fundamental
  • Price
  • PRE $12.32
  • IGA $9.52
  • Analyst Decision
  • PRE Buy
  • IGA
  • Analyst Count
  • PRE 1
  • IGA 0
  • Target Price
  • PRE $32.00
  • IGA N/A
  • AVG Volume (30 Days)
  • PRE 193.4K
  • IGA 42.3K
  • Earning Date
  • PRE 11-10-2025
  • IGA 01-01-0001
  • Dividend Yield
  • PRE N/A
  • IGA 8.93%
  • EPS Growth
  • PRE N/A
  • IGA N/A
  • EPS
  • PRE N/A
  • IGA N/A
  • Revenue
  • PRE $57,051,000.00
  • IGA N/A
  • Revenue This Year
  • PRE $202.46
  • IGA N/A
  • Revenue Next Year
  • PRE $103.60
  • IGA N/A
  • P/E Ratio
  • PRE N/A
  • IGA N/A
  • Revenue Growth
  • PRE 256.82
  • IGA N/A
  • 52 Week Low
  • PRE $3.10
  • IGA $7.77
  • 52 Week High
  • PRE $17.99
  • IGA $8.88
  • Technical
  • Relative Strength Index (RSI)
  • PRE 44.20
  • IGA 32.20
  • Support Level
  • PRE $12.05
  • IGA $9.38
  • Resistance Level
  • PRE $13.89
  • IGA $9.64
  • Average True Range (ATR)
  • PRE 1.42
  • IGA 0.10
  • MACD
  • PRE -0.47
  • IGA -0.03
  • Stochastic Oscillator
  • PRE 11.91
  • IGA 28.05

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.

Share on Social Networks: